Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C)

Contemporary Clinical Trials(2021)10.1016/j.cct.2021.106632Source: DataRank Database

Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C) is a research paper published in Contemporary Clinical Trials (2021). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.97)OA: hybridTopics (42)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Marianthi Markatou ORCID,Elisavet M. Sofikitou ORCID,Lawrence S. Brown ORCID,Ponni Perumalswami ORCID,Amreen Dinani ORCID

Live enrichment

PubMed:34813962 OpenAlex:https://openalex.org/W3215115642

Patient-Centered Outcomes Research Institute

Grant: IHS-1507-31640

Gilead Sciences

National Institutes of Health

Administration for Community Living

Eli Lilly and Company

Merck

Kaleida Health Foundation

Abbott Laboratories

Agency for Healthcare Research and Quality

Campbell Foundation

AbbVie

FWCI

1.97

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.sciencedirect.com/science/article/pii/S1551714421003682/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S1551714421003682/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1551714421003682?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714421003682?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cct.2021.106632

Fields of Study

Hepatitis C virus researchDiabetes Management and EducationHIV, Drug Use, Sexual RiskAntiviral AgentsHepacivirusHepatitis CHepatitis C, ChronicHumansOpiate Substitution TreatmentOpioid-Related DisordersPatient-Centered CareProspective StudiesTelemedicine

MeSH Terms

Antiviral AgentsHepatitis CHumansOpioid-Related DisordersProspective StudiesHepacivirusTelemedicinePatient-Centered CareHepatitis C, ChronicOpiate Substitution Treatment

Keywords

MedicineTelemedicineOpioid use disorderHepatitis CSpecialtyReferralRandomized controlled trialHealth careHepatitis C virusPopulationEmergency medicineOpioidInternal medicineFamily medicineVirologyVirusStepped-wedge DesignPragmatic Clinical TrialPersons With Opioid Use Disorder